Main news


Association between catheter ablation of atrial fibrillation and mortality or stroke Catheter ablation of atrial fibrillation was associated with a reduction in the primary endpoint of all-cause mortality or stroke. This result was driven by a marked reduction in all-cause mortality.



Death of a Sibling Linked to an Increased Risk for Early-Onset Heart Disease People who experience the death of a sibling as children or in adulthood may be at an increased risk of developing cardiovascular illnesses.



Short-Stay Units May Be a Safe Alternative for Patients With HF Quality of life for patients with acute heart failure (AHF) managed in a short-term unit (SSU) is no worse than that for those who are hospitalized, a new randomized trial showed. They also had an increased chance of being alive and out of hospital at 30 days and did not experience more adverse events, results suggested.



New Insights Into Mortality in Takotsubo Syndrome Quality of life for patients with acute heart failure (AHF) managed in a short-term unit (SSU) is no worse than that for those who are hospitalized, a new randomized trial showed. They also had an increased chance of being alive and out of hospital at 30 days and did not experience more adverse events, results suggested.



Study Identifies Cardiovascular Comorbidities Associated With Dermatomyositis Dermatomyositis (DM) is associated with an increased risk for cardiovascular comorbidities, including chronic kidney disease, a new study found.



High-Sensitivity Troponin Offers AMI Diagnostic Edge Implementing the high-sensitivity troponin (hsTn)-based HEART pathway in US emergency departments (EDs) improves acute myocardial infarction (AMI) diagnosis.



No Impact of Race on Cardiovascular Risk Calculations Removing race and incorporating social determinants of health (SDOH) into the pooled cohort risk equations (PCEs) for predicting atherosclerotic cardiovascular disease (ASCVD) outcomes made no difference to patients' risk scores.



Obesity Associated With More Severe Outcomes in Multisystem Inflammatory Syndrome in Children Obesity appears to be more prevalent in patients with multisystem inflammatory syndrome in children (MIS-C) than in children with Kawasaki disease, according to a new study. In addition, obesity is associated with more severe presentation, laboratory results, and outcomes of MIS-C than Kawasaki disease.



Alcohol and CV Risk: Both Beneficial and Harmful Effects? The relationship between alcohol consumption and cardiovascular disease (CVD) may be more nuanced than previously thought, with evidence emerging that alcohol use may both increase and decrease the risk for CVD.



SCD Mortality Rates Improved for Black Patients in 2010s The average age of death for Black U.S. patients with sickle cell disease (SCD) rose from 39 years (females = 40, males = 38) in 1999-2009 to 43 years (females = 44, males = 41) in 2010-2020, reflecting improvements in treatment, a new study finds.


New Marker of Cardiovascular Risk Discovered in T2D
New Marker of Cardiovascular Risk Discovered in T2D A significant quantity of dysfunctional monocytes appears to indicate poor cardiovascular prognosis in patients with type 2 diabetes.


New Score Predicts Risk for Death on Heart Transplant List
New Score Predicts Risk for Death on Heart Transplant List Allocation score, called the US candidate risk score (US-CRS), outperformed the current therapy-based 6-status system in rank ordering heart transplant candidates by medical urgency.


Editorial Activity

cardiology book

ECG Deep-Learning Algorithm Predicts Mortality Post Surgery
ECG Deep-Learning Algorithm Predicts Mortality Post Surgery Algorithm interpreting preoperative ECGs can identify risk for postoperative death in those undergoing cardiac surgery, noncardiac surgery, and interventional procedures, a large new study showed. The algorithm was more effective in identifying high-risk patients who went on to experience postoperative mortality than a widely used risk tool.


FDA Approves First Pulsed Field Ablation System for AF
FDA Approves First Pulsed Field Ablation System for AF The US Food and Drug Administration (FDA) has approved the PulseSelect Pulsed Field Ablation (PFA) System (Medtronic) for the treatment of both paroxysmal and persistent atrial fibrillation (AF), the manufacturer has announced.


A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic Syndrome
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic Syndrome A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led to the conceptualization of cardiovascular-kidney-metabolic syndrome. The confluence of metabolic risk factors and chronic kidney disease within cardiovascular-kidney-metabolic syndrome is strongly linked to risk for adverse cardiovascular and kidney outcomes.


In memory of Umida Kabirovna Kamilova
In memory of Umida Kabirovna Kamilova November 21, 2023. Passed away at the age of 61. Professor Umida Kabirovna Kamilova, Doctor of Medical Sciences. She devoted her life and work to medicine.


ACC/AHA Issue Updated Atrial Fibrillation Guideline
ACC/AHA Issue Updated Atrial Fibrillation Guideline The American College of Cardiology (ACC), the American Heart Association (AHA), the American College of Chest Physicians (ACCP), and the Heart Rhythm Society (HRS) have issued an updated guideline for preventing and optimally managing atrial fibrillation (AF).


One step closer to the new frontiers of healthcare for cardiomyopathy patients
One step closer to the new frontiers of healthcare for cardiomyopathy patients There were great advances in the treatment of heart failure (HF) over the past decades, characterised by the inclusion of ARNI and SGLT2 inhibitors in the latest guidelines. The use of cardiac myosin inhibitors specifically for patients with hypertrophic cardiomyopathy (HCM) is also making large steps forward, which reflects the next step towards more personalised treatment.


Roles for cardiologists in government, research councils and regulatory sectors
Roles for cardiologists in government, research councils and regulatory sectors Clinicians have numerous opportunities to gain experience in governmental or regulatory organisations, including health technology assessment bodies and payors. These organisations often seek advice from individuals with clinical experience and knowledge, and they increasingly engage with the clinical community on a regular basis. Cardiologists can also take on formal advisory roles, either through working groups or ad hoc and standing committees. Additionally, there may be part-time or full-time employment opportunities available, often providing leadership in research councils.


Al Stethoscope rolled out to 100 GP clinics to help diagnose heart failure
Al Stethoscope rolled out to 100 GP clinics to help diagnose heart failure GP clinics in London and Wales will receive an AI-powered tool as part of a trial to help improve the diagnosis of a deadly heart condition.